Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab–sarotalocan sodium in a patient with oropharyngeal cancer: A case report

Background: Photoimmunotherapy (PIT) using cetuximab–sarotalocan sodium (CS) is a novel therapy for unresectable or locally recurrent head and neck squamous cell carcinoma (HNSCC). CS is a conjugate of cetuximab (monoclonal antibody targeting epidermal growth factor receptor [EGFR]) and IR700 (light...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Respiratory Medicine Case Reports
المؤلفون الرئيسيون: Sho Takuma, Masato Karayama, Risa Suzuki, Koichi Miyashita, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Elsevier 2025-01-01
الموضوعات:
Cetuximab
Cetuximab-sarotalocan sodium
Photoimmunotherapy
Drug-induced interstitial lung disease
Lung injury
Interstitial pneumonia
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2213007125000966

الانترنت

http://www.sciencedirect.com/science/article/pii/S2213007125000966

مواد مشابهة